儿童复发性免疫性血小板减少症的危险因素与疾病轨迹
这项回顾性研究纳入1988年1月至2019年12月间497例新诊断且血小板<30×10⁹/L的儿童免疫性血小板减少症(ITP)患者,分析复发性ITP的病程与结局。29例(5.8%)出现48次复发,诊断至复发中位时间22个月,多发生于1.5-10岁且有近期感染史的儿童。多因素分析显示年龄1.5-10岁(HR 3.65,95%CI 1.35-9.82)和7-12个月延迟缓解(HR 4.04,95%CI 1.37-11.95)为复发预测因素。
要点
- 497例新诊断ITP儿童中29例(5.8%)复发,共48次复发事件。
- 复发多在1.5-10岁、有近期感染史的儿童,诊断至复发中位22个月。
- 年龄1.5-10岁(HR 3.65)与7-12个月延迟缓解(HR 4.04)为复发预测因素。
核心结论
- 复发性ITP患者症状多为轻微或轻度、血小板计数较高、不需要治疗,并在12个月内达到缓解。
- 首次与复发ITP的缓解轨迹相似,但与非复发ITP的病程不同,提示复发性ITP可能有独特的生物学基础。
研究设计与样本
- 回顾性研究,纳入1988年1月至2019年12月间497例新诊断且血小板<30×10⁹/L的儿童ITP患者。
- 复发性ITP定义为无治疗缓解至少3个月后出现新的血小板减少事件。
主要发现
- 29例(5.8%)儿童经历48次复发事件,诊断至复发中位时间22个月。
- 复发多见于1.5-10岁且有近期感染史的儿童。
- 与无复发ITP相比,复发性ITP患儿缓解延迟,诊断后1个月和3个月血小板计数更低。
- 多因素分析显示年龄1.5-10岁(HR 3.65,95%CI 1.35-9.82)和7-12个月延迟缓解(HR 4.04,95%CI 1.37-11.95)为复发预测因素。
- 多数复发性ITP患者症状轻微或轻度、血小板计数较高、不需要治疗,并在12个月内达到缓解。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This retrospective study aimed to analyse the course and outcome of recurrent immune thrombocytopenia (ITP) in children and to identify factors associated with recurrence. A total of 497 newly diagnosed ITP children with platelet <30 × 109/L between January 1988 and December 2019 were included. Recurrent ITP was defined as a new event of thrombocytopenia after at least 3 months of remission without treatment. Twenty-nine (5.8%) children experienced 48 recurrent episodes. The median time from diagnosis to recurrence was 22 months. Most recurrences occurred in children aged 1.5-10 years with a recent infection history. Compared to non-recurrent ITP, children with recurrent ITP had delayed remission with lower platelets at 1 month and 3 months postdiagnosis. Multivariate analysis identified aged 1.5-10 years (hazard ratio [HR] 3.65, 95% confidence interval [CI]: 1.35-9.82) and delayed remission at 7-12 months (HR 4.04, 95% CI: 1.37-11.95) as predictors for recurrence. Most recurrent ITP patients had minor or mild symptoms, higher platelet counts, did not require treatment, and achieved remission within 12 months. The similar remission trajectories among the first and recurrent ITP, but different from the courses in the non-recurrent ITP, suggest that recurrent ITP might have a unique biological basis.
引用
- Yang YN, Chen LW, Chen JS, et al. Risk factors and disease trajectories of recurrent immune thrombocytopenia in children. Br J Haematol. 2024. PMID: 39438259. doi:10.1111/bjh.19857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。